05.16.2022 - By PeerVoice
Visit https://www.peervoice.com/BND860 to view the entire programme with slides. After completing “‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B”, participants will be able to: Summarise the risk factors associated with the development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB); Identify when and in whom HCC surveillance should be initiated; and Apply best practice in HCC surveillance for patients with CHB.